Shelton Capital Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,687
| Closed | -$212K | – | 735 |
|
|
2023
Q1 | $212K | Hold |
3,687
| – | – | 0.01% | 662 |
|
|
2022
Q4 | $207K | Buy |
+3,687
| New | +$207K | 0.02% | 630 |
|
|
2022
Q3 | – | Sell |
-3,953
| Closed | -$214K | – | 702 |
|
|
2022
Q2 | $214K | Hold |
3,953
| – | – | 0.01% | 639 |
|
|
2022
Q1 | $254K | Hold |
3,953
| – | – | 0.01% | 636 |
|
|
2021
Q4 | $265K | Hold |
3,953
| – | – | 0.01% | 624 |
|
|
2021
Q3 | $271K | Hold |
3,953
| – | – | 0.01% | 602 |
|
|
2021
Q2 | $270K | Hold |
3,953
| – | – | 0.01% | 630 |
|
|
2021
Q1 | $273K | Hold |
3,953
| – | – | 0.01% | 596 |
|
|
2020
Q4 | $257K | Sell |
3,953
-341
| -8% | -$22.2K | 0.01% | 558 |
|
|
2020
Q3 | $203K | Hold |
4,294
| – | – | 0.01% | 682 |
|
|
2020
Q2 | $202K | Sell |
4,294
-233
| -5% | -$11K | 0.01% | 587 |
|
|
2020
Q1 | $202K | Sell |
4,527
-200
| -4% | -$8.92K | 0.01% | 533 |
|
|
2019
Q4 | $275K | Hold |
4,727
| – | – | 0.02% | 569 |
|
|
2019
Q3 | $284K | Sell |
4,727
-325
| -6% | -$19.5K | 0.02% | 544 |
|
|
2019
Q2 | $282K | Buy |
5,052
+4,771
| +1,698% | +$266K | 0.02% | 573 |
|
|
2019
Q1 | $5.05K | Sell |
281
-4,771
| -94% | -$85.8K | 0.02% | 574 |
|
|
2018
Q4 | $228K | Hold |
5,052
| – | – | 0.02% | 624 |
|
|
2018
Q3 | $333K | Buy |
+5,052
| New | +$333K | 0.02% | 535 |
|
|
2018
Q2 | – | Sell |
-6,182
| Closed | -$342K | – | 867 |
|
|
2018
Q1 | $342K | Buy |
6,182
+751
| +14% | +$41.5K | 0.02% | 496 |
|
|
2017
Q4 | $260K | Hold |
5,431
| – | – | 0.02% | 659 |
|
|
2017
Q3 | $274K | Sell |
5,431
-507
| -9% | -$25.6K | 0.02% | 605 |
|
|
2017
Q2 | $324K | Buy |
5,938
+371
| +7% | +$20.2K | 0.02% | 530 |
|
|
2017
Q1 | $235K | Buy |
5,567
+727
| +15% | +$30.7K | 0.02% | 712 |
|
|
2016
Q4 | $208K | Buy |
+4,840
| New | +$208K | 0.02% | 810 |
|